Viewing Study NCT05596734


Ignite Creation Date: 2025-12-25 @ 2:39 AM
Ignite Modification Date: 2026-01-07 @ 3:04 PM
Study NCT ID: NCT05596734
Status: COMPLETED
Last Update Posted: 2025-07-23
First Post: 2022-10-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza
Sponsor: BioNTech SE
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-10-28
Start Date Type: ACTUAL
Primary Completion Date: 2023-12-28
Primary Completion Date Type: ACTUAL
Completion Date: 2023-12-28
Completion Date Type: ACTUAL
First Submit Date: 2022-10-26
First Submit QC Date: None
Study First Post Date: 2022-10-27
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-12-19
Results First Submit QC Date: None
Results First Post Date: 2025-07-23
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-02
Last Update Post Date: 2025-07-23
Last Update Post Date Type: ACTUAL